Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Webcast: China Update 2023: How will recent developments impact your brand’s success?

May 10, 2023 | China, emerging markets, webinar 

Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.

- PMLiVE

Wednesday May 31, 2023 – 10:00 – 10:30 EDT / 15:00 BST / 16:00 CEST

For decades, China has had the largest population in the world. However, recent demographic trends have resulted in India being the world’s most populous country. COVID-19, an aging population and low birth rate have all contributed to the decrease in China’s population growth, but what does this really mean to the pharmaceutical industry?

Watch this webcast, in which our in-house experts, Marc Yates and Peggy Yau, explain the impact of the demographic shift, and the new policies that have been introduced. They provide an in-depth understanding of the pharma landscape in China which offers exciting potential, such as the breakthrough of biosimilars, the vaccination boom and Healthy China 2030 policy. The presenters further showcase where to play and how to win, providing examples spanning from market access to clinical trial design and patient journey research.

What are the takeaways?

  • Learn about the implications of the changing demographics on the healthcare landscape
  • Discover Research Partnership’s take on ‘where to play, how to win’ in China
  • Understand how to maximize your market research across key stakeholder groups in China

Watch here

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...